Psychedelic News

/by Tags:,

Interview With Doug Drysdale, CEO, Cybin Inc

Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.

Get a Roundup of Psychedelic News Stories in Your Inbox.

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

"We are committed to leveraging this pledge as a powerful guide and resource to help us earn trust and to never lose sight of our ability to help contribute to the greater good of humanity," says our CEO David Flores.

Why the Psychedelic Drug Market is Experiencing Major Growth

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company's digital media platform 'Psychedelic Spotlight', factors contributing to a more open-minded approach to psychedelics among the scientific and medical…

Psychedelic Spotlight Interview with Douglas K. Gordon

In this episode of the Psychedelic Spotlight podcast, we connect with Douglas K. Gordon, CEO of Silo Wellness, a wellness company in the psychedelics and functional mushroom marketplace. In our conversation with Douglas, we discuss the company's…

Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders

Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.
Here's How Many Billions of Dollars the Global Psychedelic Market May Be Worth by 2026

Here’s How Many Billions of Dollars the Global Psychedelic Market May Be Worth by 2026

Recent analysis cites positive results of clinical psychedelic trials, coupled with a large amount of capital investment into biotech companies.
Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

"We are committed to leveraging this pledge as a powerful guide and resource to help us earn trust and to never lose sight of our ability to help contribute to the greater good of humanity," says our CEO David Flores.
Psychedelic Business Spotlight: September 17, 2021

Psychedelic Business Spotlight: September 17, 2021

This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across the Nordics.
United States' First Actively Managed Psychedelics ETF Launches on NYSE Arca

United States’ First Actively Managed Psychedelics ETF Launches on NYSE Arca

PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier this year.
How 4 Indigenous Cultures Currently Use Psychedelics

How 4 Indigenous Cultures Currently Use Psychedelics

Explore how the Mazatecs, the Shipibo People, Yanomami People, and Africans practicing the Bwiti religion continue to use various entheogens to this day.
How Mind Medicine Australia is Tackling Australia’s Mental Health Crisis with Psychedelics

How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics

Charity co-founder Tania de Jong says Covid-19 pandemic has led to "a huge spike in mental health issues including, very sadly, suicides," and she believes psychedelics are a solution.

Why the Psychedelic Drug Market is Experiencing Major Growth

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company's digital media platform 'Psychedelic Spotlight', factors contributing to a more open-minded approach to psychedelics among the scientific and medical…

Psychedelic Spotlight Interview with Douglas K. Gordon

In this episode of the Psychedelic Spotlight podcast, we connect with Douglas K. Gordon, CEO of Silo Wellness, a wellness company in the psychedelics and functional mushroom marketplace. In our conversation with Douglas, we discuss the company's…

Psychedelic Spotlight Interview with Rabbi Zac Kamenetz

In this episode of the Psychedelic Spotlight podcast, we speak with Rabbi Zac Kamenetz, the Founder, and CEO of Shefa and the Co-Founder of the Jewish Psychedelic Summit. In our conversation with Rabbi Zac, we discussed the forthcoming Jewish…

Psychedelic Spotlight Interview with Joshua White

In this episode of the Psychedelic Spotlight podcast, we speak with Joshua White, the Co-Founder and Director of Fireside Project, the first Psychedelic Peer Support Line. Joshua speaks about the creation of the Fireside Project and the future…

Psychedelic Spotlight Interview with Pierre Bouchard

In this episode of the Psychedelic Spotlight podcast, we speak with Pierre Bouchard, a psychotherapist from Boulder, CO. Pierre talks about the delivery of ketamine therapy and what patients can expect going into a session. *Get the latest…

Psychedelic Spotlight Interview with Timothy Ko

In this episode of the Psychedelic Spotlight podcast, we spend some time with Timothy Ko who is the CEO of Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) (FSE: “1XU1”), a biotechnology company focused on developing psychedelic medicines…

Psychedelic Spotlight Interview with David Champion

In this episode of the Psychedelic Spotlight podcast, we speak with David Champion who is the Co-Founder and CEO of Maya Health, a company dedicated to empowering psychedelic practitioners with the technology and insight they need to scale…

HAVN Life Sciences Update

HAVN Life Sciences Inc. CEO, Tim Moore, updates the recent launch of its new line of natural health products and more. *To learn more about the company featured in this video and the work they’re doing, visit their website: https://havnlife.com…

Senator Scott Wiener Discusses Senate Bill 519

In this Psychedelic Spotlight exclusive, we speak with California Senator, Scott Wiener (D-San Francisco), to discuss Senate Bill 519 (SB-519) which aims to decriminalize the possession and sharing of certain psychedelics within the state…

Psychedelic Spotlight Interview with Anthony Tennyson

In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction. In our conversation…

Psychedelic Spotlight Interview with Daniel Carcillo

In this episode of the Psychedelic Spotlight podcast, we catch up with Daniel Carcillo, Founder, and CEO of Wesana Health, to talk about the company's recent listing on the #CSE, their plans to uplist to the NASDAQ, and their recently formed…

Psychedelic Spotlight Interview with James Hallifax

In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor, an emerging media company covering the medicinal psychedelics space and partner of Psychedelic Spotlight. In our conversation…
Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Podcaster and author of "The 4-Hour Work Week" will gift the university's Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.

Interview With Doug Drysdale, CEO, Cybin Inc

Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.

Psychedelic Drug Use Among College Students Increased During Covid-19 Pandemic

Annual survey finds college students drank less during the pandemic, in favor of smoking more marijuana and experimenting with hallucinogens.
Detroit Voters Can Decriminalize Psychedelic Plants This November

Detroit Voters Can Decriminalize Psychedelic Plants This November

The proposal asks voters if the city should "decriminalize to the fullest extent permitted under Michigan law the personal possession and therapeutic use of entheogenic plants by adults."
Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve

Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve

"HPPD is a discomfort. Some people have it for 10, 15, 20 years and they regret the day they did the drug that caused it," says the CEO of Ehave.
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

"Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
The Legal Status of Psychedelics Around the World

The Legal Status of Psychedelics Around the World

In Brazil, there have been no instances of an individual being punished for the consumption, cultivation, or possession of magic mushrooms.
Psychedelic Business Spotlight: Big Week for Research and Clinical Trials

Psychedelic Business Spotlight: September 10, 2021

This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.
Moms on Mushrooms: Inside the Psychedelic Parenting Trend

Moms on Mushrooms: Inside the Psychedelic Parenting Trend

They’re not quite hippies, and they’re not quite 20-year-olds on the search for existential assurance. Nope. They’re moms, and they’re coming out of the psychedelic closet to share how microdosing has helped them become better parents.

Walled Garden: Fighting for Inclusivity and Accessibility in the Psychedelic Renaissance

As the new industry blooms, researchers and other professionals are fighting to break down barriers to participation, information, and psychedelics themselves.
University of Ottawa Offers Canada's First Psychedelic Studies Program

University of Ottawa Offers Canada’s First Psychedelic Studies Program

And since the classes are online, students can live anywhere in the world while taking Psychedelic and Spiritual Studies courses at the university.
Michigan Senators Propose Bill Legalizing Plant-Based Psychedelics

Michigan Senators Propose Bill Legalizing Plant-Based Psychedelics

"Decriminalization of entheogenic substances makes sense," says Senator Jeff Irwin. "Let's stop wasting time and money making more victims of the War on Drugs."

Interview With Michelle Janikian, Author, Host & Editor at Psychedelics Today

Michelle opens up about how her work as a cannabis writer led her down the path of psychedelics, her interest in safe magic mushroom use and why she was compelled to write her guidebook Your Psilocybin Mushroom Companion.
4 Ways Psychedelics Can Positively Transform Women's Mental Health

4 Ways Psychedelics Can Positively Transform Women’s Mental Health

Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.

Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%

The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
3 Reasons Why Diversity, Equity and Inclusion Matter in the Psychedelic Industry

Why Diversity, Equity and Inclusion Are Vital to the Psychedelic Industry

Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should "harness the power of diversity."
Psychedelic Business Spotlight: September 3, 2021

Psychedelic Business Spotlight: September 3, 2021

"Magic Truffle" producer and distributor Red Light Holland has had a very busy week, and Filament Health files a "milestone" patent.
Ketamine One Clinics Offer Scented Virtual Reality Psychedelic Trips

Ketamine One Partners with OVR Technology to Provide Scent-Enabled VR Psychedelic Experiences

Take a whiff of the latest development in virtual reality technology available to further immerse patients in psychedelic-assisted therapy.

DEA Proposes Huge Increase to Psilocybin and Psilocin Quotas for Research Purposes

In its proposed revised 2021 quotas, the DEA suggests 4900% increase in the allowed quantities of psilocybin for research and clinical trial purposes.
Take Tastier Trips with This Psilocybin Cookbook

The Joy of Cooking with ‘Shrooms: Making Psilocybin More Palatable

Virgina Haze, the co-author of "The Psilocybin Chef Cookbook," promises a psychedelic experience "can be delicious as well as trippy."
Psychedelic Sector Reaches International Supply Chain Milestones

Psychedelic Sector Reaches International Supply Chain Milestones

Canadian psychedelics production company Red Light Holland announces largest legal sale and import of psilocybe truffles.

Interview With Steven Huang, DEI Consultant at MAPS and Numinus

Steven's consultancy company, Millennial HR Design, focuses on the intersection of DEI and psychedelics, where he intends to be a leverage point for the psychedelics industry to better understand their impact on marginalized communities. With nearly 10 years of industry experience, Steven hopes for more diverse and equitable representation in the psychedelic space. 
How to Navigate a 'Bad Trip' on Psychedelics

How to Navigate A Challenging Psychedelic Trip

,
Psychedelic facilitator and guide Nick Levich shares his best advice for facing inevitable discomfort during these profound experiences.
Mindset Pharma's DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge

Mindset Pharma’s DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge

,
“The data suggests that we have a new drug that may be at least as effective, if not more effective, than 5-MeO-DMT and, more importantly, it looks like it is much safer," says Mindset Pharma CEO James Lanthier.
Stoned Ape Theory 101: Pseudoscience or Psychedelic Wonder?

The Stoned Ape Theory: Pseudoscience or Psychedelic Origin of Modern Man?

Did early humans accelerate evolution by tripping balls on psychedelic mushrooms? One psychonaut ethnobiologist says: absolutely.
Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia

Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia

“Australian native ‘magic mushrooms’ may have evolved different methods for psilocybin production and offer adaptations that are preferential for use in clinical treatments," explains University of Queensland mycologist Dr. Alistair McTaggart.
I Drank a 'Mushroom Latte' Every Morning for Two Weeks: Here's How I Felt

I Drank a ‘Mushroom Latte’ Every Morning for Two Weeks: Here’s How I Felt

Everyday Dose is a tasty coffee replacement, which is easy to make and loaded with healthy benefits.
California Bill Decriminalizing Psychedelics Delayed Until 2022

California Bill Decriminalizing Psychedelics Delayed Until 2022

SB 519 would decriminalize the personal use of psilocybin, psilocyn, MDMA, LSD, DMT, mescaline (excluding peyote), and ibogaine, including in group counseling and community-based healing settings.
Psychedelic Business Spotlight: August 27, 2021

Psychedelic Business Spotlight: August 27, 2021

Delic establishes medical board to oversee psychedelic treatment protocols, cool new delivery systems investigated for psychedelics, and VR meets psychedelic therapies, finally. 
MindSet Pharma Says Its Proprietary Psilocybin Formula Is the 'Perfect Microdosing Drug'

MindSet Pharma Says Its Proprietary Psilocybin Formula Is the ‘Perfect Microdosing Drug’

"The potential market for microdosing could be absolutely enormous because it is easier, more convenient, and more familiar," says Mindset Pharma CEO James Lanthier.
Kacey Musgraves Says ‘Life-Changing’ Psilocybin Trip Transformed Her Trauma Into New Album

Kacey Musgraves Says ‘Life-Changing’ Psilocybin Trip Transformed Her Trauma Into New Album

This isn't the first time the hit songwriter has turned to psychedelics for therapy, either.
MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders

MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders

MindMed is currently conducting several clinical trials using psychedelic-inspired medicines, including studying LSD experiential therapy for anxiety, LSD microdosing for adult ADHD, and 18-MC for opioid withdrawal.

Interview With Chris Kilham, Medicine Hunter Inc.

Chris works alongside companies to develop plant-based food and medicinal products, helping turn them into market successes. He has conducted medicinal plant research and sustainable botanical sourcing in over 45 countries, and has been featured on a number of platforms such as The New York Times, The Dr. Oz Show, Business Insider, CNN, VICE, and much more. 
3 Microdosing Alternatives to Relieve Stress

3 Microdosing Alternatives to Relieve Stress

Although the trend is hot, it's still largely illegal, so consider incorporating these three stress relievers into your life. They're free, effective, and legal.
University of Wisconsin-Madison Launches New Psychedelic Research Center

University of Wisconsin-Madison Launches New Psychedelic Research Center

This school offers the first accredited American degree focused on the study and therapeutic development of psychedelic compounds and related psychoactive drugs.
TRIPP Acquires PsyAssist to Empower Psychedelic Therapies with Virtual Reality

TRIPP Acquires PsyAssist to Empower Psychedelic Therapies with Virtual Reality

Clinicians are currently using TRIPP to help immerse patients into alternative realities and to support patients’ wellbeing before, during, and after ketamine-assisted therapy.
Psychedelics May Decrease Racial Trauma Symptoms Among People of Color

Psychedelics May Decrease Racial Trauma Symptoms Among People of Color

Study authors write, "Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience."

Decriminalize Nature Co-Founder Carlos Plazola Wants to Free Entheogens Everywhere

,
Since May 2019, nine cities and the state of Oregon have decriminalized psychedelics. Carlos Plazola has had his hand in nearly all of them. 
Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.

Psychedelic Business Spotlight: August 20, 2021

This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing. 

Spiritual Tourism: The Toxic Impact on Indigenous Peoples and Ethical Steps Forward as Psychedelics Boom

Jessika Lagarde, the co-founder of Women on Psychedelics, explores the negative impacts of psilocybin-fueled spiritual tourism on the Mazatec people in Mexico, and offers ideas for more ethical steps forward.
Field Trip Health Expands Access to Ketamine-Assisted Psychotherapy

Field Trip Health Expands Access to Ketamine-Assisted Psychotherapy

Although based in Canada, the company is building a clinical network of therapists trained in ketamine-assisted psychotherapy across the United States.
Does Ayahuasca Change Personality Like Other Psychedelics? Study Says No

New Study Explores If Ayahuasca Changes Personality Like Other Psychedelics

Recent ayahuasca study concludes mixed messages in attempt to determine if the ancient plant medicine has power to change personality, as psilocybin has shown.
Reishi Mushrooms to treat breast cancer

Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast Cancer

,
The company is also pursuing psilocybin as a possible treatment for rare cancers, but they see huge potential in researching the medicinal effects of the reishi mushroom.

Interview With Evan Levine, PsyBio Therapeutics

In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health issues and other disorders.
Why PsyBio Is Using Biosynthetic Psilocybin, Not Magic Mushrooms, to Build Better Therapeutics

Why PsyBio Is Using Biosynthetic Psilocybin, Not Mushrooms, to Build Better Therapeutics

"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his company's method of biologically engineering psilocybin is "cheaper, faster, greener."
Canada Green Lights Country’s Third Clinical Psilocybin Study

Canada Green Lights Country’s Third Clinical Psilocybin Study

The trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses of psilocybin hold the potential to treat psychiatric disorders, including anxiety and depression.
'Have a Good Trip' Director Donick Cary Prepares Sequel 'The Adventures Continue'

‘Have A Good Trip’ Director Donick Cary Prepares a Second Dose: ‘The Adventures Continue’

The filmmaker behind the Netflix hit tells us a sequel or a series is on the way, as well as which celebrities may share more psychedelic adventures.
Beckley Psytech Raises $80 Million to Fund Psychedelic Research Pipeline

Beckley Psytech Raises $80 Million to Fund Psychedelic Research Pipeline

,
The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in patients suffering from a rare headache condition with no approved medications to treat it.
First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

Researchers hope to establish whether the effects of microdosing are as profound as people say they are, since previous studies could not rule out placebo effect.

Interview With Henri Sant-Cassia

In today’s episode of the Psychedelic Spotlight podcast, we spotlight Henri Sant-Cassia, Co-Founding Partner of The Conscious Fund, a leading investment fund in the medicinal psychedelics industry, focused on early stage ventures and psychedelic medicine that are helping to deliver better outcomes for mental health, addiction and pain.
How Ayahuasca and Volcanic Disaster Pulled Microdosing Mentor Laura Dawn Out of the 'Psychedelic Closet'

How Ayahuasca and Volcanic Disaster Pulled Microdosing Mentor Laura Dawn Out of the ‘Psychedelic Closet’

,
The Psychedelic Spotlight podcast guest also addresses criticism that she is a white woman working with sacred plant medicine, and how that inspired her next non-profit venture.
Psychedelic Business Spotlight: August 13, 2021

Psychedelic Business Spotlight: August 13, 2021

This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain, and eating disorders.
What Is Salvia Divinorum and How Can the Psychedelic Help Humanity?

What Is Salvia Divinorum and How Can the Psychedelic Help Humanity?

Take a deep dive into the history, effects, and benefits of this psychoactive plant that is still largely under the radar as interest in psychedelics explodes.
Nova Mentis Reaches Milestone Developing Psilocybin to Treat Autism

Nova Mentis Reaches Milestone Developing Psilocybin to Treat Autism

,
Nova Mentis says that psilocybin could be a novel, first-in-class treatment for a brain disorder that leads to learning disabilities and behavioral problems.
Wesana Health Launches Animal Studies for Psilocybin and TBI

Wesana Health Launches Animal Studies for Psilocybin and TBI

,
According to the CDC, about 166 Americans die from TBI-related conditions each day.
A Brief History of Magic Mushrooms Across Ancient Civilizations

A Brief History of Magic Mushrooms Across Ancient Civilizations

Just like any good trip, the history of psilocybin has many colorful and surprising turns.
What Is Ketamine Therapy

Nushama Opens Psychedelic Wellness Clinics in NYC

The clinics provide high-dose ketamine infusions, as well as intramuscular ketamine infusions for group therapy.

Interview With Laura Dawn

In today’s episode of the Psychedelic Spotlight podcast, we feature Laura Dawn- a microdosing mentor, visionary life coach, business consultant, author, international speaker, and host of the Psychedelic Leadership podcast.
5 Ways Psychedelics Can Help Humanity

5 Ways Psychedelics Can Help Humanity with Medicinal Benefits You Never Imagined

DMT treating eye disease? Psilocybin reducing obesity? The benefits of psychedelics could be truly far out as research continues to find novel applications.
7 'Fantastic Fungi' Facts From Psychedelic Mushroom Documentary on Netflix

7 ‘Fantastic Fungi’ Facts We Learned From Psychedelic Mushroom Documentary on Netflix

Now streaming on Netflix, this critically acclaimed film gives viewers a glimpse into a clinical psilocybin trip while revealing that mushrooms have so much more to offer humanity.
Watch Deepak Chopra Blow Your Mind About Connection Between Consciousness, Psychedelics, Disease

Watch Deepak Chopra Blow Your Mind About Connection Between Consciousness, Psychedelics, Disease

The spiritual wellness author recommends "combining meditation, music, psychedelics, and a little bit of explanation that reality is not what you're seeing."
Contract Research Organizations Partner to Accelerate European Psychedelic Clinical Trials

Contract Research Organizations Partner to Accelerate European Psychedelic Clinical Trials

A partnership between Clerkenwell Health and Transpharmation provides drug developers a one-stop-shop for all stages of psychedelic research.
Can a Compound in ‘Magic’ Mushrooms Cure Social Anxiety

Surveys Show: America’s Public Approval of Psychedelic Therapy Lags Behind Canada

,
We compare two polls of roughly the same sample size in two neighboring countries, and find a stark difference in attitudes.
Filament Health Patents Natural Extraction Technique for Superior, Cheaper Psilocybin

Filament Health Patents Extraction Technique for Superior, Cheaper Natural Psilocybin

The Vancouver-based company says it has overcome the challenges of natural extraction with its new technology, which can produce superior psilocybin at a lower cost.
Psychedelic Business Spotlight: August 6, 2021

Psychedelic Business Spotlight: August 6, 2021

Another clinic gets approval to conduct MDMA research, and new psychedelic research facilities open in Australia and the U.S., plus two game-changing psilocybin patents.

Why Dimensions Health Centers Founders Embrace Plant Medicine Ceremonies Over Clinical Treatment

CEO Christopher Dawson and COO Andrew Galloway spent years working in clinical mental health treatment centers before betting big on psychedelics and ancient healing methods.
Why These Researchers Are Concerned About Psychedelic Legalization

Why These Researchers Are Concerned About Psychedelic Legalization

Two researchers argue we still can’t be sure what the effects of widespread public use of psychedelics would be, and point to possible negatives.

The Spotlight Roundup- This Psychedelic VR Startup Raises Over $11 Million

August 4, 2021- This week’s Psychedelic Business News top stories include: - Virtual reality startup, Tripp Inc., raises $11 million - Research from Numinus involving psychedelics for PTSD makes significant strides - We catch up with…
FDA Green Lights Ketamine for Treatment of ALS

FDA Green Lights Ketamine for Treatment of ALS

,
"This designation not only expedites our regulatory, clinical, and product development plans but also validates our belief in the potential of ketamine," says PharmaTher CEO Fabio Chianelli.
Fireside Project Releases App for Psychedelic Peer Support

Fireside Project Releases App for Psychedelic Peer Support

"Our app was designed with accessibility and ease of use as top priorities, so that psychedelic users in any state of mind can connect quickly with our diverse and compassionate peer support line volunteers," says the nonprofit's co-founder.

Interview With Dimensions Health Centers

In today’s episode of the Psychedelic Spotlight podcast, we spotlight Dimensions Health Centers who are creating a new paradigm for hospitality by helping people to improve and transform their lives by drawing on the restorative power of nature, spa rituals, delicious food, and psilocybin-inspired ceremonies in safe, legal and luxurious settings.
Majority of Canadians Support Psilocybin-Assisted Therapy, According to New Poll

Majority of Canadians Support Psilocybin-Assisted Therapy, According to New Poll

As a result, the Canadian Psychedelic Association responds with a Memorandum of Regulatory Approval, which advises medicinal psilocybin therapy to be authorized in a safe and therapeutic environment.

Mindset Pharma Files Patent for Quickest, Cheapest Method to Synthesize Psilocybin

"Based on our research, we think we're able to get to psilocybin in fewer steps than any of the other published methods," says the company's CEO.
Australia’s First Psychedelic Research Institute Psychae Opens with $40 Million Investment

Australia’s First Psychedelic Research Institute Opens with $40 Million Investment

Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.
Grand Rapids May Be Second City in Michigan to Decriminalize Natural Psychedelics by Year’s End

Grand Rapids May Be Second Michigan City to Decriminalize Natural Psychedelics by Year’s End

City Commissioner Kurt Reppart believes there is enough support to pass a resolution as early as fall.
How the Heroic Hearts Project Is Spearheading Psilocybin Research to Treat Veterans for TBI

How the Heroic Hearts Project Is Spearheading Psilocybin Research to Treat Veterans for TBI

Dr. Grace Blest-Hopley tells Psychedelic Spotlight that the compound has anti-inflammatory effects on the brain, and explains how her team will investigate further through psilocybin retreats for veterans.
Matthew McConaughey Cuddles a Mountain Lion - 5 Wildest Celebrity Trips on Psychedelics

Matthew McConaughey Climbed in a Cage with a Mountain Lion? 5 Wildest Celebrity Trips on Psychedelics

From Carrie Fisher’s shirtless surprise for Japanese tourists to Gary Busey getting dosed by a co-star on set, these crazy trips are almost too wild to believe.
Psychedelic Spotlight Business Round Up July 30

Psychedelic Business Spotlight: July 30, 2021

This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
Oregon Psilocybin Advisory Board Finds the Psychedelic Reduces Depression and Anxiety

Oregon Psilocybin Advisory Board Finds the Psychedelic Reduces Depression and Anxiety

The subcommittee’s review is the largest of its kind to be conducted in the state, which legalized psilocybin for therapeutic and medicinal purposes last November.
TheraPsil's Fight to Secure Therapeutic Psilocybin Access for All Canadians

TheraPsil’s Fight to Secure Therapeutic Psilocybin Access for All Canadians

CEO Spencer Hawkswell calls current exemptions for terminally ill under Section 56 of Canada’s Controlled Drugs and Substances Act a "half-assed solution," and is lobbying for more.
Pennsylvania Lawmakers to Propose Legalizing Psilocybin for Therapeutic Use

Pennsylvania Lawmakers to Propose Legalizing Psilocybin for Therapeutic Use

Republican Tracy Pennycuick and Democrat Jennifer O’Mara are the latest politicians to take notice of the proven therapeutic use of psilocybin.

Interview With Spencer Hawkswell

In this episode of the Psychedelic Spotlight podcast, we speak with Spencer Hawkswell, CEO of TheraPsil.
Ayahuasca May Help Curb Drug and Alcohol Addiction

Ayahuasca May Help Curb Drug and Alcohol Addiction

New study compiles the experiences of 8,629 ayahuasca users from 40 different countries, and results are very promising for the future of psychedelic-assisted therapy.
Psychedelic Companies HAVN Life Sciences, MINDCURE Health Reach Manufacturing Milestones

Psychedelic Companies HAVN Life Sciences, MINDCURE Health Reach Manufacturing Milestones

The global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.
Akome Biotech Patents Psychedelic Drug Formulation to Treat Parkinson's Disease

Akome Biotech Patents Psychedelic Drug Formulation to Treat Parkinson’s Disease

,
There is currently no known cure for the disease affecting 10 million people worldwide, but this psychedelics company thinks it has found a "viable candidate" using DMT.
AOC Is Trying (Again) to End 'Ridiculous' War on Drugs to Further Psychedelics Research

AOC Is Trying (Again) to End ‘Ridiculous’ War on Drugs to Further Psychedelics Research

AOC says she is "undeterred" after her previous effort to change laws drew laughs from congressional colleagues.

Interview With James Hallifax

In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor.
How a Psilocybin Study on AIDS Survivors Could Solve a Big Problem with Psychedelic Therapy

How a Psilocybin Study on AIDS Survivors Could Solve a Big Problem with Psychedelic Therapy

,
A group psilocybin study paves the way for increased scalability of novel treatments that typically require a lot of time for both the patient and therapist.
Psychedelic Business Spotlight: July 23, 2021

Psychedelic Business Spotlight: July 23, 2021

This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus another psychedelic company inches toward listing on NYSE American stock exchange.
Cybin Receives Conditional Approval to Trade on NYSE American

Cybin Receives Conditional Approval to Trade on NYSE American

And in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging psychedelics-related companies.
Building Better Psychedelic Playlists

A Club DJ’s Advice on Building Better Psychedelic Playlists

Psychedelic playlists should minimize lyrics, focus on building an emotional arc, and other helpful tips to improve your trips.
Megan Pormer incredible Ketamine experience

Megan Pormer Calls Ketamine ‘One of the Most Incredible Experiences of My Life’ While Talking Psychedelics with Lamar Odom

The Iranian model, actress and scientist bonds with former NBA star over spiritual experiences with deceased loved ones during psychedelic trips.
Wake Network Developing Genetics-Based Screening System to Offer Patients Personalized Psychedelic Therapies

Wake Network Partners with Lieber Institute to Develop Genetics-Based Screening System for Psychedelic Therapies

, ,
Fungi bioscience company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space to date."

Interview With Jemie Sae Koo

In this episode of the Psychedelic Spotlight podcast, we feature Jemie Sae Koo, CEO and Founder of Psychable.

The Spotlight Roundup-Can Psychedelics Help Brain Trauma?

July 21, 2021- This week’s Psychedelic Business News top stories include: - Wesana Health & The University of Southern Carolina Team up To Develop More Effective Treatments for TBI - The World's Largest Psychedelic Trial To Date Achieves…

Free Ketamine Treatment Now Available for Canadian Veterans

Medavie Blue Cross partners with medical research company Braxia Scientific to cover ketamine care for veterans at Canadian Rapid Treatment Centres of Excellence.
Levitee Labs joins Canadian Securities Exchange CSE

Levitee Labs to Begin Trading on the CSE This Week

The emerging wellness company aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies.
'PSY' Becomes First U.S.-Listed Psychedelic ETF

Third Psychedelic Stock ETF Coming Soon, Core One Labs Prepares to List on NASDAQ

Advisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL.
Traumatic Brain Injury (TBI) psychedelic treatment daniel carcillo

How Wesana Health CEO Daniel Carcillo Plans to Protect Athletes From Traumatic Brain Injury

,
And why the two-time Stanley Cup champion does not imagine working with the NHL in the "near future."
Psychedelic Business Spotlight, July 16

Psychedelic Business Spotlight: July 16, 2021

This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.
COVID-19 Pandemic Study of Ketamine Amplifies Antidepressant Potential

COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant Potential

,
Study authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."

Global Trac Solutions Expands Investment in Psychedelic App PsycheDev and You Can Test It Out

The PsycheDev app guides users through intention setting, meditation, learning, contemplation and questioning, serving as a virtual facilitator and integration coach.
Psychedelics Companies PsyBio Therapeutics and Silo Wellness Start Trading on the OTCQB Venture Market

Psychedelics Companies PsyBio Therapeutics and Silo Wellness Start Trading on the OTCQB Venture Market

The OTCQB is a middle-tier market for entrepreneurial and development stage American and international companies.
Psychedelics Decriminalization Bill Clears Another Hurdle in California

Psychedelics Decriminalization Bill Clears Another Hurdle in California – But Not Without Controversy

The state's Assembly Public Health Committee wants to set legal limits on possession amount, and at least one advocacy organization thinks that's a problem.

Interview With Daniel Carcillo

In this episode of the Psychedelic Spotlight podcast we catch up with Daniel Carcillo, Founder and CEO of Wesana Health.
Awakn Life Science CEO Anthony Tennyson "Groundbreaking" MDMA discovery

Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat Addiction

, ,
Anthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that MDMA interacts with that we believe nobody else in the world knows about."
Wesana Health to Acquire Psytech

Wesana Health to Acquire Psychedelic Therapy and Software Company PsyTech

, ,
The deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.
Megan Fox ayahuasca therapy

Ayahuasca Sent Megan Fox to ‘Hell for Eternity’ and It Was Better than Therapy

The actress is the latest celebrity to give ayahuasca a shot, following in the footsteps of Miley Cyrus and Chelsea Handler.
Psychedelics asthma treatment

Why Psychedelics Could Eventually Treat Asthma

,
Researchers continue to explore anti-inflammatory nature of psychedelics, which in small doses, may alleviate asthma symptoms.
Microdosing cancer patients LSD study

New Zealand Psychologist Assembles First Study Microdosing Cancer Patients with LSD

University of Auckland researcher hopes the psychedelic treatment will enhance the effect of psychotherapy, easing end-of-life distress in patients.

Interview With Anthony Tennyson

We speak with Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.
Psychedelic clinical trials looking for volunteers

Want to Try Psychedelics in a Clinical Setting? 56 Trials Now Recruiting Volunteers

,
Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, and 5-MeO-DMT studies.
HGTV Star Christina Haack Says Smoking Bufo Toad Cured Her Anxiety in '15 Minutes'

HGTV Star Christina Haack Says Smoking Bufo Toad Cured Her Anxiety in ‘15 Minutes’

The famous interior designer known for renovating and flipping houses credits the potent psychoactive substance for resetting her brain.
Psychedelic Business Spotlight

Psychedelic Business Spotlight: July 9, 2021

This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
Michael Pollan advice for talking to kids about drugs

Michael Pollan’s Advice on Talking to Kids About Psychedelic Drugs: ‘They Need to Be Treated with Respect’

"We can begin to talk to children about drugs in a very different way than they're learning in school," the popular author says.

The Spotlight Roundup-The First-Ever Female Founded Psychedelic Company

July 7, 2021- This week’s Psychedelic Business News top stories include: - Mydecine Innovations Group Makes A Huge Mushroom Discovery - Field Trip Health Prepares for the Nasdaq - Psychedelic Research Makes It's Way To Texas - We Introduce…
Third California City Considers Decriminalizing Psychedelics

Another California City Proposes Decriminalizing Psychedelics

Decriminalization is one step behind legalization. Selling entheogenic plants or fungi remains a felony that could warrant prison time.
Psilocybin depression treatment

Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment

, ,
Cybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."

Single Dose of Psilocybin Strengthens Brain Connections in Mice, According to Yale Study

“It was a real surprise to see such enduring changes from just one dose of psilocybin," says senior study author Alex Kwan.
Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

Numinus Wellness to Acquire Neurology Centre of Toronto to Create Psychedelic Treatment Facility

,
NCT will utilize Numinus' expertise in psychedelic-assisted therapy to create a specialization in the application of psychedelics in the field of neurology

The Spiritual Reason Michael Pollan Explores Mescaline in New Book ‘This Is Your Mind on Plants’

The author's latest deep dive into plants' effect on consciousness also investigates caffeine and opium.
Psychedelics Domestic Violence

Can Psychedelics Reduce Domestic Violence? New Study Suggests Yes

Alcohol, methamphetamine and cocaine have been linked to increased aggression in men, but psychedelics appear to have opposite effect.
Psychedelic Business Spotlight

Psychedelic Business Spotlight: July 2, 2021

This week in psychedelic business news: Companies embrace the psychedelic aspects of VR, Braxia trains therapists in psychedelic best practices, and Allied gears up to provide its psychedelic formulation to PTSD patients.

Psychedelic Movie Spotlight: 3 Strange Trips to Stream This Weekend

Enjoy one of these three movies exploring psychedelia, now streaming on Netflix or Amazon.

Harvard Law Launches Psychedelics Regulation Research Project

,
POPLAR is the first academic initiative focused on psychedelics law and policy.
How to Become a Psychedelic Facilitator

How to Become a Psychedelic Facilitator

As psychedelic medicine gains momentum, a growing number of organizations are offering psychedelic facilitator programs. Here's how to become one.
Psychedelics and Depression

Havn Life to Cultivate Psilocybin in Jamaica through Hypha Wellness Partnership

Havn Life Sciences is expanding its psilocybin cultivation in Jamaica where the psychedelic mushrooms are legal to grow.
Predicting Psychedelic Experience Outcomes Through Machine Learning

Predicting Psychedelic Experience Outcomes Through Machine Learning

New technology that employs machine learning is helping researchers predict psychedelic experience outcomes.

Interview With Lauren Taus

In this episode of the Psychedelic Spotlight podcast we speak with Lauren Taus who is the Founder of INBodied Life, who's focus is on integrating modern science and ancient wisdom to support transformation.

Interview With Tesla La Touche

In this episode of the Psychedelic Spotlight podcast, we spend some time with Tesla La Touche who is the Founder and CEO of Aphrodite Health, the first ever female-founded biotech company within the medicinal psychedelic industry. 
The Benefits of Peyote: Ancient Wisdom, Modern Medicine

‘Meaningful’ Mescaline Experience Linked to Improvements in Depression, Anxiety

Significant personal experiences on the psychedelic mescaline show great promise in treating anxiety and depression, new research finds.
Queen’s University Launches Psychedelic Research Collaborative

Queen’s University Launches Psychedelic Research Collaborative

Ontario’s Queen’s University’s is launching a psychedelics research collaborative to serve as a space for innovation, and education.
PSYCHED 2021 Conference Aims to Bring the Global Psychedelic Community Together

PSYCHED 2021 Conference Aims to Bring the Global Psychedelic Community Together

The Psyched 2021 conference is aiming to bring the global psychedelic community together over nine days in July.
UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

A research team from the University of Nevada at Las Vegas have discovered a brainwave signature that responds to psychedelic treatments.
Wesana Health and University of South Carolina Partner on Psychedelic Brain Research

Wesana Health and University of South Carolina Partner on Psychedelic Research for Brain Injuries

Psychedelic life sciences company Wesana Health has partnered with the University of South Carolina to study brain health.
First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists

First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists

A new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their patients.

Psychedelic Business Spotlight: June 25, 2021

This week in psychedelic business news: A next-gen psychedelic for stroke care, a major merger, and two more companies list on NEO Exchange.
Former Director of Psychiatric Products at FDA Joins Psychedelic Life Sciences Company Cybin

Former Director of Psychiatric Products at FDA Joins Psychedelic Life Sciences Company Cybin

Former Food and Drug Administration division director Dr. Thomas Laughren has joined the psychedelic life sciences team at Cybin.
Silo Wellness Launches 'Marley One' Brand of Functional and Psychedelic Mushrooms

Silo Wellness Launches ‘Marley One’ Brand of Functional and Psychedelic Mushrooms

The Bob Marley-inspired line of psychedelic and functional mushrooms, Marley One, has officially launched through partner Silo Wellness.
Imperial College and Heroic Hearts Launch Psychedelic Research Retreat for Veterans with Head Trauma

Imperial College and Heroic Hearts Launch Psychedelic Research Retreat for Veterans with Head Trauma

,
A new veterans research-focused psychedelic retreat in partnership between Heroic Hearts and Imperial College looks at treating brain injuries.
Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction

Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction

,
A new platform is aimed at psychedelic experience integration and harm reduction by surveying practitioners and patients.

Spotlight Roundup-Another Psychedelic Company Lists On The Nasdaq

June 9, 2021- This week’s Psychedelic Business News top stories include: - MindMed Prepares For Its First Clinical Trial on Mescaline - Another Psychedelic Company Makes Its Way To the Nasdaq - Maya Health Develops a Data-Driven Platform…
The University of Alabama Joins League of Research Facilities Granted Approval to Study Psychedelics

The University of Alabama Joins League of Research Facilities Granted Approval to Study Psychedelics

The University of Alabama at Birmingham is the latest to announce it will begin research into psychedelics.
Berlin Has An LSD Shop Run By a Donald Trump Relative

Berlin Has An LSD Shop Run By a Donald Trump Relative

A shop in Berlin run by a man who claims to be related to former U.S. President Donald Trump, is legally selling an LSD analog.
How The Multidisciplinary Association for Psychedelic Studies Is Changing Mental Health Treatment

How The Multidisciplinary Association for Psychedelic Studies Is Changing Mental Health Treatment

The Multidisciplinary Association for Psychedelic Studies has been studying mental health treatment for more than 35 years. Here's what to know.

The Spotlight Roundup-Is California Next For Legalizing Psychedelics?

June 22, 2021- This week’s Psychedelic Business News top stories include: - California Takes A Big Step Forward Towards Legalizing Psychedelics - Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects On The Brain - Mind Cure Health…

Texas Governor Signs Bill to Test Psychedelics As PTSD Treatment for Veterans

,
Texas Gov. Greg Abbott signed a bill requiring the state to study the risks and benefits of psychedelics for veterans suffering with PTSD.
Atai Life Sciences Valued At More Than $3 Billion After IPO

Atai Life Sciences Valued At More Than $3 Billion After IPO

German psychedelic pharmaceutical company Atai Life Sciences is valued at more than $3 billion after its IPO listing on the Nasdaq.
Publicly-Traded Psychedelic Stocks

27 Publicly-Traded Psychedelic Stocks Investors Have Their Eyes On

These psychedelic stocks are all publicly trading. Take a look at the companies leading the psychedelic medicine revolution.
Psychedelic Business Spotlight: June 18, 2021

Psychedelic Business Spotlight: June 18, 2021

This week in psychedelic business news: Patent progress for biosynthetic psilocybin, psychedelics for brain health, and psychedelic and cannabis companies team up in the name of research.
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression

Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression

Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
Bringing Next-Gen Depression Treatment to Market: PharmaTher's Ketamine Patch

Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine Patch

Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
Can Taking Psychedelics Change Your Political Beliefs? It's Complicated.

Can Taking Psychedelics Change Your Political Beliefs? It’s Complicated.

Will taking psychedelics turn you into a liberal hippie? Here's everything you need to know about psychedelics and political beliefs.
40 'New' Psychedelic Compounds Found In More Than 25 Species of Mushrooms

40 ‘New’ Psychedelic Compounds Found In More Than 25 Species of Mushrooms

Mydecine Innovations Group says it has found 40 new compounds in at least 25 types of mushrooms with psychedelic and potentially therapeutic properties.

Ask A Psychedelic Guide

We welcome back Nick Levich for our "Ask a Psychedelic Professional" series and as part of our "Ask a Psychedelic Guide" episode.
The War On Drugs May Finally Be Over: Decriminalization Legislation Comes to Congress

The War On Drugs May Finally Be Over: Decriminalization Legislation Comes to Congress

Representatives Cori Bush and Bonnie Watson Coleman have introduced legislation to end the federal war on drugs once and for all.
Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Is synthetic psilocybin as effective as the real thing? A new study looks at the risks and benefits of taking this lab-made psychedelic.
University of Calgary Creates Canada’s First Chair for Psychedelic Research

University of Calgary Creates Canada’s First Chair for Psychedelic Research

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Psilocybin May Treat Phantom Limb Syndrome

80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.

New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.
Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuation

Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuation

Atai Life Sciences is the latest psychedelic company to announce plans to IPO. The Peter Thiel-backed biotech startup is valued at more than $2 billion.
Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

New research into psychedelics shows it may help scientists better understand the phenomenon known as near-death experiences.
Psychedelic Business Spotlight: June 11, 2021

Psychedelic Business Spotlight: June 11, 2021

This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.
Psychedelic Genetic Test Kit

First-of-Its-Kind Genetic Psychedelic Test Kit Now Available In U.S.

The first genetic psychedelic test kit is now available in the U.S. The kits are designed to help users know how they'll respond to psychedelics.
Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics

Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics

Seattle city council members are being asked to review decriminalizing psychedelics.
Psilocybin Shows Promise As Treatment for Migraines

Psilocybin Shows Promise As Treatment for Migraines

A new investigation into treatment for migraines spotlights the psychedelic psilocybin mushroom as a promising prospect.
Connecticut Governor Signs Psychedelic Reform Deal

Connecticut Governor Signs Psychedelic Reform Deal

Connecticut has become the newest state to consider reform proposals regarding psychedelic medicines.